369 related articles for article (PubMed ID: 22841998)
21. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.
Sadhukha T; Layek B; Prabha S
Drug Deliv Transl Res; 2018 Apr; 8(2):375-386. PubMed ID: 28462499
[TBL] [Abstract][Full Text] [Related]
22. A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug.
Alvi MM; Chatterjee P
AAPS PharmSciTech; 2014 Apr; 15(2):339-53. PubMed ID: 24357111
[TBL] [Abstract][Full Text] [Related]
23. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
Fisher SJ; Swaan PW; Eddington ND
J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
[TBL] [Abstract][Full Text] [Related]
24. The effect of hyperosmosis on paracellular permeability in Caco-2 cell monolayers.
Inokuchi H; Takei T; Aikawa K; Shimizu M
Biosci Biotechnol Biochem; 2009 Feb; 73(2):328-34. PubMed ID: 19202294
[TBL] [Abstract][Full Text] [Related]
25. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
26. The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.
Alani AW; Rao DA; Seidel R; Wang J; Jiao J; Kwon GS
J Pharm Sci; 2010 Aug; 99(8):3473-85. PubMed ID: 20198687
[TBL] [Abstract][Full Text] [Related]
27. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
[TBL] [Abstract][Full Text] [Related]
29. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
30. Correlation of in vitro cytotoxicity with paracellular permeability in mortal rat intestinal cells.
Konsoula R; Barile FA
J Pharmacol Toxicol Methods; 2007; 55(2):176-83. PubMed ID: 16891127
[TBL] [Abstract][Full Text] [Related]
31. Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers.
Aspenström-Fagerlund B; Sundström B; Tallkvist J; Ilbäck NG; Glynn AW
Chem Biol Interact; 2009 Oct; 181(2):272-8. PubMed ID: 19576870
[TBL] [Abstract][Full Text] [Related]
32. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure.
Al-Ali AAA; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828
[TBL] [Abstract][Full Text] [Related]
33. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
34. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
[TBL] [Abstract][Full Text] [Related]
35. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.
Brayden DJ; Gleeson J; Walsh EG
Eur J Pharm Biopharm; 2014 Nov; 88(3):830-39. PubMed ID: 25460147
[TBL] [Abstract][Full Text] [Related]
36. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
37. Self-nanoemulsifying performance of two grades of Lauroglycol (Lauroglycol-90 and Lauroglycol-FCC) in the presence of mixed nonionic surfactants.
Shakeel F; Haq N; Alanazi FK; Alsarra IA
Pharm Dev Technol; 2014 Nov; 19(7):799-805. PubMed ID: 23964928
[TBL] [Abstract][Full Text] [Related]
38. Functionalized carbon nanomaterials: exploring the interactions with Caco-2 cells for potential oral drug delivery.
Coyuco JC; Liu Y; Tan BJ; Chiu GN
Int J Nanomedicine; 2011; 6():2253-63. PubMed ID: 22125408
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of a novel oral insulin formulation.
Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants.
Jakobsen S; Gaenaelle Gé L; Pedersen M; Griffin BT; Holm R; Uhd Nielsen C
Int J Pharm; 2022 Aug; 624():121885. PubMed ID: 35690306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
